Back to results
US 7,402,404 B2Granted
Assay method for measurement of net cholesterol flux
AssigneeThe Children's Hospital of Philadelphia
InventorsGeorge H. Rothblat, Ginny Kellner-Weibel
Life of this patent
Estimating the term…
Abstract
The present invention relates to an assay for determining net cholesterol flux from lipid loaded cells in the presence of an acceptor (e.g., serum). The present invention also relates to a method for evaluating efficacy of a therapeutic agent for stimulating or inhibiting net cholesterol flux. Also provided by the present invention are kits that are used to carry out the aforementioned assays and methods.
Claims17
A method for determining net cholesterol flux from cholesterol containing cells following exposure to a cholesterol acceptor, comprising the steps of:
- a) providing detectably labeled cholesterol containing cells;
- b) determining a first specific activity for said cholesterol containing cells;
- c) exposing said cholesterol containing cells to a cholesterol acceptor and at least one cholesterol synthesis inhibitor for a period of time sufficient enough to allow cholesterol flux to occur;
- d) determining cholesterol efflux by measuring the amount of detectably labeled cholesterol in the media;
- e) measuring the cellular cholesterol mass and determining a second specific activity;
- f) determining cholesterol influx from the reduction in said second specific activity compared to said first specific activity;
- and
- g) comparing said cholesterol efflux to said cholesterol influx, wherein a net cholesterol efflux is present when cholesterol efflux is greater than the cholesterol influx and wherein a net cholesterol influx is present when cholesterol influx is greater than the cholesterol efflux.
5 more elements
Dependencies are inferred from the claim text.